ELITE PHARMS INC (ELTP) Total Assets by Year
ELITE PHARMS INC closed fiscal year 2026 with $138.3M in total assets, $39.4M in total liabilities and $98.9M in shareholder equity. This represents an increase of 43.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters ELITE PHARMS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ELTP Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $138.3M+43.5% | $96.4M+15.2% | $83.7M+104.6% | $40.9M+16.4% | $35.1M+34.2% | $26.2M+4.9% | $25.0M+2.3% | $24.4M-21.0% | $30.9M-10.0% | $34.3M+8.3% | $31.7M+22.2% | $25.9M+6.6% | $24.3M+118.6% | $11.1M+7.9% | $10.3M |
| Total Liabilities | $39.4M-8.1% | $42.9M+64.4% | $26.1M+118.4% | $11.9M+20.2% | $9.9M-1.1% | $10.0M-29.8% | $14.3M-46.9% | $26.9M+2.3% | $26.3M+204.3% | $8.6M-86.7% | $64.8M+6.8% | $60.7M-42.5% | $105.5M+432.9% | $19.8M-21.7% | $25.3M |
| Total Equity | $98.9M+84.8% | $53.5M-7.1% | $57.6M+98.8% | $29.0M+14.8% | $25.2M+56.2% | $16.2M+51.6% | $10.7M+524.9% | -$2.5M-154.9% | $4.6M-82.2% | $25.7M+177.5% | -$33.1M+4.6% | -$34.7M+57.2% | -$81.2M-836.2% | -$8.7M+42.1% | -$15.0M |
ELTP Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $139.7M+25.4% | $138.3M+43.5% | $126.4M+39.3% | $117.2M+32.9% | $111.3M+26.7% | $96.4M+15.2% | $90.8M+21.5% | $88.2M+24.7% | $87.8M+88.9% | $83.7M+104.6% | $74.7M+41.7% | $70.7M+40.5% |
| Total Liabilities | $34.8M-45.3% | $39.4M-8.1% | $46.1M-15.1% | $55.7M+36.0% | $63.7M+115.1% | $42.9M+64.4% | $54.3M+92.0% | $40.9M+59.7% | $29.6M+80.7% | $26.1M+118.4% | $28.3M+25.5% | $25.6M+10.7% |
| Total Equity | $104.8M+119.8% | $98.9M+84.8% | $80.3M+120.4% | $61.6M+30.3% | $47.7M-18.1% | $53.5M-7.1% | $36.4M-21.5% | $47.3M+4.8% | $58.3M+93.4% | $57.6M+98.8% | $46.4M+53.8% | $45.1M+65.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More ELITE PHARMS INC financials
Frequently Asked Questions
What was ELITE PHARMS INC's total assets in fiscal year 2026?
ELITE PHARMS INC closed fiscal year 2026 with $138.3M in total assets, $39.4M in total liabilities and $98.9M in shareholder equity.
How fast is ELITE PHARMS INC's total assets growing?
ELITE PHARMS INC (ELTP) total assets rose by 43.5% year over year, from $96.4M to $138.3M in fiscal year 2026.
How has ELITE PHARMS INC's total assets changed over the years?
Across the 15 fiscal years this page covers, ELITE PHARMS INC (ELTP) total assets went from $10.3M in fiscal year 2012 to $138.3M in fiscal year 2026.
What was ELITE PHARMS INC's total assets in the most recent quarter?
ELITE PHARMS INC (ELTP) reported $139.7M in total assets in Q1 2027. This represents an increase of 25.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what ELITE PHARMS INC (ELTP) reported on that line in every period on record.